Telix Pharmaceuticals (TLX) Inventory (2023 - 2025)

Telix Pharmaceuticals (TLX) has 3 years of Inventory data on file, last reported at $37.1 million in Q4 2025.

• In Q4 2025, Inventory rose 48.65% year-over-year to $37.1 million; the TTM figure through Dec 2025 stood at $37.1 million (up 48.65% YoY), while the FY2025 annual figure was $37.1 million, up 56.99% from the prior year.
• Inventory advanced to $37.1 million in Q4 2025, from $24.9 million in the prior quarter.
• Across five years, Inventory topped out at $37.1 million in Q4 2025 and bottomed at $11.3 million in Q4 2023.
• A 3-year average of $24.4 million and a median of $24.9 million in 2024 frame the typical range for Inventory.
• Annual changes were most pronounced in 2024 — Inventory soared 121.36% — and 2025, when it soared 48.65%.
• Year by year, Inventory stood at $11.3 million in 2023, then soared by 121.36% to $24.9 million in 2024, then jumped by 48.65% to $37.1 million in 2025.
• The last three Inventory figures came in at $37.1 million (Q4 2025), $24.9 million (Q4 2024), and $11.3 million (Q4 2023), per Business Quant data.

Peer Comparison